Product Categories
| Country: | China |
|---|---|
| Tel: | 755-13923738421 |
| Mobile: | 13923738421 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2,5-Pyridinedicarboxylic acid, 1-(2,2-dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo- | C12H15NO8 | 2651309-06-5 | Details |
| 5-Benzamido-4-oxopentanoic acid | C12H13NO4 | 102872-00-4 | Details |
| 2(1H)-Pyrimidinone,4-amino-1-b-D-arabinofuranosyl-, 3-oxide | C9H13N3O6 | 30902-36-4 | Details |
| N'-[[(2-benzoyl-4-chlorophenyl)(chloroacetyl)amino]methylene]chloroacetohydrazide | C18H14Cl3N3O3 | 49691-65-8 | Details |
| Pentanedioic acid, 3-(3-furanyl)- | C9H10O5 | 2228413-62-3 | Details |
| 3-(2-Amino-1-chloropropyl)phenol | C9H12ClNO | 1379208-51-1 | Details |
| 6-acetyl-2-aMino-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one | C15H18N4O2 | 571189-64-5 | Details |
| 1,3-Benzodioxole, 5,5'-methylenebis- | C15H12O4 | 4971-68-0 | Details |
| Bedaquiline Impurity 5 | C32H31BrN2O2 | 916801-19-9 | Details |
| 1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, hydrochloride (1:1) | C6H14ClN5 | 352211-11-1 | Details |
| (11β,17E)-11,20-dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al | C21H28O4 | 105562-12-7 | Details |
| 2-[3-(Dimethylamino)propyl]-1,2-dihydro-1-(phenylmethyl)-3H-indazol-3-one | C19H23N3O | 52413-42-0 | Details |
| Nalmefene Impurity | C21H25NO3 | 738552-29-9 | Details |
| 3-Furancarbonitrile, 2-amino-5-(2-fluorophenyl)- | C11H7FN2O | 312307-69-0 | Details |
| Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]hydroxyamino]-, (2S)- | C17H19FN2O3 | 2270245-27-5 | Details |
| Finerenone impurity 34 | 2924224-42-8 | Details |
| NA | Details |
| Carbidopa Methyl Ester | C11H16N2O4 | 91431-01-5 | Details |
| Mirabegron Impurity Q | 1684452-92-3 | Details |
| Bedaquiline Impurity 13 | C32H32N2O2 | 2122862-01-3 | Details |
| (11β,17Z)-11,20-Dihydroxy-3-oxo-pregna-4,17(20)-dien-21-al | C21H28O4 | 105562-13-8 | Details |
| DL-METHIONINE-D3 | C5H11NO2S | 284665-20-9 | Details |
| sodium dihydrogen 2-sulphonatosuccinate | C4H5NaO7S | 29454-16-8 | Details |
| 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-, (4R,12aR)- | C21H21F2N3O5 | 2384108-28-3 | Details |
| Naltrexone 3-Methyl Ether | C21H25NO4 | 16617-07-5 | Details |
| N-(4-cyanophenyl)-2-((4-cyanophenyl)amino)acetamide | C16H12N4O | 1900865-84-0 | Details |
| Naltrexone EP Impurity H | C20H25NO4 | 503090-99-1 | Details |
| Riboflavin 4’,5’-Diphosphate | C17H22N4O12P2 | 86108-25-0 | Details |
| Dabigatran impurity 73 | C11H10N2O4 | 858967-80-3 | Details |
| 3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- | C11H14O4S | 1025974-23-5 | Details |
| Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[5-[[4-(2-hydroxyethyl)-1-piperazinyl]sulfonyl]-2-propoxyphenyl]-5-methyl-7-propyl- | C24H34N6O5S | 1339092-18-0 | Details |
| Hydrazinecarboxamide, 1-[(1S,2S)-1-ethyl-2-(phenylmethoxy)propyl]-2-formyl-N-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- | C30H37N5O4 | 2889357-64-4 | Details |
| Dabigatran Impurity i | C29H32N6O4 | 1354892-78-6 | Details |
| Naltrexone EP Impurity C | C20H23NO4 | 189016-90-8 | Details |
| Lomefloxacin Impurity 3 | C16H19F2N3O | 183235-15-6 | Details |
| 2-amino-4-ethyl-5-methylbenzene-1,3-dicarbonitrile | C11H11N3 | 55525-92-3 | Details |
| 1,3-Propanediamine, N1,N1,N3-trimethyl-N3-[3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]propyl]- | C23H32N4O | 1337966-15-0 | Details |
| 2-Hexenoic acid, 4,5-dihydroxy-, (2E,4S,5R)- | C6H10O4 | 931426-06-1 | Details |
| 2H-Pyrido[1,2-a]pyrazine-7-carboxylic acid, 1,8-dihydro-2-[(1R)-3-hydroxy-1-methylpropyl]-9-methoxy-1,8-dioxo- | C14H16N2O6 | 2710626-41-6 | Details |
| (5alpha)-4,5-Epoxy-3,14-dihydroxy-6-oxomorphinan-17-carboxaldehyde | C17H17NO5 | 1007856-83-8 | Details |
| 7H,14H-Pyrazino[1,2-b:4,5-b]diindazole-7,14-dione | C16H8N4O2 | 115660-68-9 | Details |
| 6-Hydroxy-2-naphthamide | C11H9NO2 | 62529-01-5 | Details |
| Ibrutinib Impurity 14 | C50H48N12O4 | 2417548-76-4 | Details |
| Metronidazole Impurity 3 | C6H7N3O2 | 5006-79-1 | Details |
| 161532-54-3 | C37H36F2N6O4 | 161532-54-3 | Details |
| Dobutamine Impurity 6 | C20H27NO3 | 140165-60-2 | Details |
| 2-Imidazolidinecarboxamide, N-(2,6-dimethylphenyl)-4-methyl-1-(2-methylphenyl)-5-oxo-3-propyl- | C23H29N3O2 | 2509057-86-5 | Details |
| 1H-Pyrrole-2,5-dione, 3,4-bis(hydroxymethyl)- | C6H7NO4 | 2775363-46-5 | Details |
| Benzenepropanamine, N-hydroxy-N-methyl-γ-[4-(trifluoromethyl)phenoxy]- | C17H18F3NO2 | 1624625-05-3 | Details |
| Lomefloxacin Impurity | C17H18FN3O3 | 195259-11-1 | Details |
| Ketoprofen Impurity 15 | C19H20O5 | 1257296-76-6 | Details |
| Brimonidine Impurity 14 | C15H12BrN5O3 | 934548-66-0 | Details |
| 4-((2-amino-2-oxoethyl)amino)butanoic acid | C6H12N2O3 | 1096803-44-9 | Details |
| INDEX NAME NOT YET ASSIGNED | C28H40N8O4 | 2399424-46-3 | Details |
| 2-Hexenoic acid, 4,5-dihydroxy- | C6H10O4 | 873385-02-5 | Details |
| 1-Piperazinecarbonyl chloride (9CI) | C5H9ClN2O | 69433-07-4 | Details |
| 2-Cyanoethyl (2E)-2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxobutanoate | C16H14N2O4 | 1870824-79-5 | Details |
| 4-(4-{4-[(3R,5R)-5-(2,4-DIFLUORO-PHENYL)-5-[1,2,4]TRIAZOL-1-YLMETHYL-TETRAHYDRO-FURAN-3-YLMETHOXY]-PHENYL}-PIPERAZIN-1-YL)-PHENYLAMINE | C30H32F2N6O2 | 184378-04-9 | Details |
| Pyridoxine Impurity 9 | C12H17NO3 | 1385767-86-1 | Details |
| Lomefloxacin Impurity | C17H19ClFN3O3 | 111234-01-6 | Details |
| DICHLORO-N-METHYLACETAMIDE | C3H5Cl2NO | 5345-73-3 | Details |
| Benzoic acid, 3-[[[(2S,4R)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- (9CI) | C12H14N2O4 | 770703-11-2 | Details |
| Butanoic acid, 2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxo-, ethyl ester | C15H15NO4 | 959934-80-6 | Details |
| 2H-Pyrrole-2-carboxylicacid,5-amino-3,4-dihydro-,(S)-(9CI) | C5H8N2O2 | 111631-17-5 | Details |
| NA | 362658-21-7 | Details |
| 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxoquinoline-3-carboxylic acid ethyl ester | C19H23F2N3O3 | 98079-83-5 | Details |
| NQT Impurity E | C24H29NO4 | 767615-69-0 | Details |
| Pyridoxine Impurity 5 | C12H15NO6 | 412940-03-5 | Details |
| 1487411-82-4 | C16H13N3O2S | 1487411-82-4 | Details |
| Lomefloxacin Impurity 8 | C15H18FN3O3 | 195259-19-9 | Details |
| Hydrazine amide of deoxycholic acid | C24H42N2O3 | 96840-44-7 | Details |
| Cytarabine Impurity 10 | C4H6N2O3 | 84902-98-7 | Details |
| N-Formyl-5-asa | C8H7NO4 | 104786-99-4 | Details |
| riboflavin 3',5'-bisphosphate | C17H22N4O12P2 | 86108-26-1 | Details |
| 4-METHYL-3-[[1-OXO-2-(PROPYLAMINO)PROPYL]AMINO]-2-THIOPHENECARBOXYLIC ACID | C12H18N2O3S | 114176-52-2 | Details |
| NA | Details |
| Carbidopa Ethyl Ester | C12H18N2O4 | 91908-71-3 | Details |
| Benzoic acid, 3-[[[(2S,4S)-4-hydroxy-2-pyrrolidinyl]carbonyl]amino]- | C12H14N2O4 | 266337-30-8 | Details |
| 2-(Sodiooxy)-1-cyclopentene-1-carboxylic acid methyl ester | 63178-03-0 | Details |
| Benzamide, 3-amino-4-(methylamino)-N-[3-oxo-3-(2-pyridinylamino)propyl]-N-2-pyridinyl- | C21H22N6O2 | 2931469-64-4 | Details |
| 3-[(4-chloro-3-nitrobenzoyl)pyridin-2-yl-amino]propionic acid ethyl ester | C17H16ClN3O5 | 1620205-04-0 | Details |
| 3,4-Pyridinedimethanol,5-hydroxy-6-methyl-, 1-oxide | C8H11NO4 | 16567-04-7 | Details |
| estradiol 17-sulfate | C18H24O5S | 3233-69-0 | Details |
| 2(1H)-Pyridinone, 1-(2-chlorophenyl)-5-methyl- | C12H10ClNO | 1198414-06-0 | Details |
| 2-Cyclohexen-1-one, 5-(4-chlorophenyl)-3-methyl- | C13H13ClO | 54795-01-6 | Details |
| 1-Propanamine, N-methyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]- | C18H21N3O | 32852-16-7 | Details |
| Benzoic acid, 4-hydroxy-, 4-carboxyphenyl ester | C14H10O5 | 40677-31-4 | Details |
| (R)-4,5-Dehydro Pregabalin | C8H15NO2 | 1101167-84-3 | Details |
| 2,4-Furandiol, tetrahydro-2-(hydroxymethyl)- | C5H10O4 | 136272-61-2 | Details |
| LROQBKNDGTWXET-FVWDGWMTSA-N | C17H21NO4 | 199014-26-1 | Details |
| 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy- | C10H10N2O3 | 1234834-29-7 | Details |
| 2-Ethoxy-1-(tetrazolo[1,5-f]phenanthridin-6-ylmethyl)-1H-benzimidazole-7-carboxylic acid | C24H18N6O3 | 1821386-35-9 | Details |
| 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-, 5-oxide | C16H11ClN4O | 29975-18-6 | Details |
| (5aR,10aR)-1,2,3,5a,6,7,8,10a-octahydrodipyrrolo[1,2-c:1',2'-f]pyrazine-5,10-dione | C10H14N2O2 | 53990-71-9 | Details |
| Ethyl diazophenylacetate | C10H10N2O2 | 22065-57-2 | Details |
| Impurity | C33H32N6O6 | 1821385-89-0 | Details |
| 1,3-Dioxol-2-one, 4,5-bis(hydroxymethyl)- | C5H6O5 | 1417576-03-4 | Details |
| 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-, hydrazone, (Z)- (9CI) | C15H13ClN4 | 112393-62-1 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 | ||||